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The RE1 Silencing Transcription Factor (REST) is a negative regulator of neuronal 
differentiation. It is expressed ubiquitously in early embryos, but downregulated in neural 
progenitors concomitant with onset of neuronal differentiation in these cells. REST has 
been widely studied as a negative regulator of neuronal differentiation genes. Our recent 
work identified a novel role for REST in control of cell proliferation. However, the 
underlying molecular mechanism(s) are not known and is a focus of the current thesis 
project. Here, we provide evidence that REST signaling controls the expression of the 
cyclin-dependent kinase inhibitor, p16Ink4a, a negative regulator of the cell cycle and 
passage through G1. We determined that REST expression in the proliferating granule 
progenitors of the cerebellum and its lack of expression in the differentiated neurons is 
reciprocally correlated with that of p16Ink4a. Decline in REST levels in differentiating 
primary and neural stem cells immortalized with v-myc (NSC-M) granule progenitors in 
vitro was also associated with upregulation of p16Ink4a expression. Conversely, constitutive 
human REST transgene expression in NSC-M cells (NSC-MRs) blocked p16Ink4 
upregulation, even under neuronal differentiation conditions. However, the lack of a 
consensus REST DNA binding RE1 element in the regulatory regions of p16Ink4a locus 
suggested an indirect regulation of p16Ink4a by REST. Based on work from other groups 
that showed repression of p16Ink4a transcription by the polycomb protein Bmi-1, and its 
negative regulation by microRNA-203 (miR-203) and our identification of a RE1 element 
in the downstream regulatory region of miR-203, we asked if the p16Ink4a expression was 
  vi 
controlled by REST through a series of negative regulatory events involving miR-203 and 
Bmi-1. We observed that Bmi1 -expression mirrored that of REST and inversely 
correlated with that of miR-203 in the postnatal cerebellum and in vitro differentiated 
granule and NSC-M progenitors. In contrast, forced REST transgene expression in NSC-
MR cells abrogated the decrease in Bmi-1 levels and elevation in miR-203 expression. 
Significant REST binding to the miR-203 RE1 element was also observed in NSC-M cells, 
indicating that REST had the potential to directly regulate miR-203 expression. In 
conclusion, our studies suggest a role for REST in control of cell cycle transit in neural 
progenitors through negative regulation of p16Ink4a. Further validation of these results in 
REST knockout mice is needed, and is ongoing.  
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Chapter 1 
Introduction 
 2 
Control of Proliferation and Differentiation in the Cerebellum. 
The cerebellum is the region of the brain that is important for coordinating 
motion and balance, motor learning, and higher cognitive functions. The cerebellum 
develops from the posterior neural tube (1, 2). Although it composes only about 10% of 
total brain volume, it contains more than half of the neurons in the brain (1, 2). In 
humans, the cellular organization of the cerebellum is in flux for approximately one year 
after birth (1), making it highly vulnerable to developmental irregularities, such as 
medulloblastoma (MB), a highly malignant pediatric brain tumor.   
The cerebellum is derived from cells in the ventricular zone and the rhombic lip 
(1, 2). The subventricular zone (SVZ) is compromised of the Purkinje cells of the 
cerebellar cortex and the Bergman glia cells (1, 2). The rhombic lip gives rise to the 
granular neural precursors, or cerebellar progenitor cells (CPCs) (Fig. 1A and 1B) (1, 2). 
In mice, the Purkinje cells develop around embryonic day (E) 13, and, shortly thereafter, 
migrate radially over the already formed deep cerebellar nuclei (Fig. 1B). There they 
settle beneath the external granular layer (EGL), awaiting the inward migration of the 
CPCs (1). At approximately E11, CPCs begin their first round of proliferation in the 
rhombic lip and initiate their migration over the surface of the cerebellum to form the 
outer EGL at approximately E27 (1). These cells display the proliferation markers Math1 
and Nestin (Fig. 1A) (1, 4, 5). The CPCs in the outer EGL undergo their second round of 
proliferation shortly after birth (1).  
There are four major pathways that control CPC expansion, the Sonic hedgehog 
(SHH) pathway, the Notch pathway, the Wingless (Wnt) pathway, and the Bone 
Morphogenic Protein (Bmp) negative growth regulator pathway (6-9). SHH was the first 
 3 
key mitogen discovered to promote CPC neurogenesis (6) and its role in neurogenesis 
has been extensively studied. For CPC proliferation to occur post-natally, the Purkinje 
cells secrete SHH (1, 2, 10).  SHH ligand binds to the Patched (PTCH) receptor found on 
the membrane of CPCs in the outer EGL (7, 10) (Fig. 1C). In the absence of SHH, 
PTCH1 binds to Smoothened (Smo), a G-protein coupled receptor necessary for SHH- 
mediated signaling. Its association with PTCH prevents its translocation into the nucleus. 
Thus, when SHH is present, PTCH1 dissociates from Smo, and the latter then signals the 
CPCs in the EGL to expand and proliferate (7, 10). 
Eventually, CPCs switch from a proliferation stage to a differentiating stage 
through cell-intrinsic mechanisms. The SHH mitogenic pathway contains a negative 
feedback loop that drives CPC cell cycle exit. In the presence of SHH, β-arrestin 1 
(βArr1), a negative regulator of G-protein coupled receptors such as Smo, begins to 
accumulate (11). Subsequently, βArr1 is phosphorylated at serine 412, causing a 
translocation from the cytoplasm to the nucleus where it participates with CREB and 
p300 to enhance expression of cyclin dependent kinase inhibitor p27Kip1 (11). 
Accumulation of p27Kip1 ultimately drives CPC cell cycle exit, causing the CPCs to 
begin migrating downward, forming post-mitotic neurons within the inner EGL (Fig. 
1D).  These post-mitotic neurons express early neuronal differentiation markers such as 
p27kip1, NeuroD and neuron-specific class III β-tubulin (Tuj1) (1, 10, 12).  They 
subsequently undergo terminal differentiation, extending axons that form synapses with 
Purkinje cells as they continue to migrate through the molecular layer to form mature 
neurons in the IGL (Fig. 1D) (10). The neurons in the IGL express neuronal 
differentiation markers such as Synapsin1 and Synaptophysin.   
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In human cerebellar development, most cells in the IGL differentiate into 
neurons after the first year concomitant with disappearance of the EGL. However, since 
the cerebellum takes approximately a year to fully develop, it is highly susceptible to 
developmental irregularities. Mutations in the genes of the SHH pathway have been 
linked to excessive proliferation and account for about 30% of sporadic MB tumors (Fig. 
1E) (1). A balance between positive and negative regulators of neurogenesis prevents 
these irregularities from occurring. In 1995, two groups independently identified a gene 
known as the Repressor element 1 (RE1) Silencing Transcription Factor (REST)/Neuron-
Restrictive Silencer Factor (NRSF), a negative regulator of neuronal phenotype (13, 14).  
Subsequent studies identified a critical role for REST as a negative regulator of neuronal 
genes in embryonic stem cells (ESC), neural stem cells (NSC)/progenitor cells, and non-
neural cells (15-19). 
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Figure 1: Cerebellar Development. A.) and B.): The rhombic lip gives rise to the 
cerebellar progenitor cells (CPCs) that migrate toward the outer external granular 
layer (EGL) while the ventricular zone gives rise to the Purkinje neurons and 
Bergmann glia that settle beneath the EGL. C.) The Purkinje cells secrete a mitogen, 
Sonic hedgehog, (SHH) that signals the CPCs in the EGL to expand and proliferate. 
D.) Cessation of SHH signaling promotes CPC migration to the inner EGL to form 
post-mitotic neurons. These cells then differentiate and continue to migrate through 
the molecular layer and become terminally differentiated neurons in the internal 
granular layer (IGL) (Fig. 1D). E.) Repressor element 1 (RE1) Silencing Transcription 
Factor (REST) is a major regulator of cerebellum development (13, 14). (Adapted 
from Dahmane and Altaba, 1999 and Wang and Zoghbi, 2001)  
A. 
B. 
D. C. 
E. 
ML 
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 REST is a Repressor of Neuronal Differentiation Genes 
REST is a transcriptional repressor of neuronal differentiation genes (14). It is 
found in human, mouse, chick, fugu, and many other organisms (19, 20). In mice, REST 
expression is highest in non-neural cells of the developing embryo, where neuronal 
genes must be silenced (17). Studies of REST null mice showed they have malformed 
brains, exhibit ectopic expression of some neuronal differentiation genes and die early in 
development at E11.5. (19). REST is also expressed in ESCs, NSCs, and non-neural cells, 
but is downregulated in most neurons, consistent with its role as a negative regulator of 
neuronal genes (13, 14, 19, 21, 37). This suggests REST may be important for brain 
development in vertebrates. 
REST is a 116 kDa zinc finger protein that contains a DNA binding domain 
localized within a central cluster of eight zinc finger domains (Fig. 2A) (13, 15). REST 
has a proline-rich region and a lysine-rich region that contains one of its nuclear 
localization signals (NLS) (Fig. 2A) (13, 15). The other NLS is found on zinc finger 5 
(13, 15). It also has two separate repressor domains located at the amino-(N) and 
carboxy-(C) terminus (Fig. 2A) (13, 15). The N-terminal repressor domain interacts with 
mSin3A while the C-terminal repressor domain interacts with CoREST (15, 22). Both 
repressor domains recruit histone deacetylase (HDACs) silencing complexes to remodel 
chromatin and repress gene expression (15, 22). In addition, REST contains two degron 
sequences in the c-terminus (23, 24). 
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Figure 2: Structure of REST protein and its DNA binding Consensus Sequence. 
A.) REST contains a DNA binding domain (DBD) localized within a cluster of eight 
zinc finger domains. It has two nuclear localization signals (NLS), one on zinc finger 
5 and the other in the Lys-rich sequence.  It also contains two degron sequences in the 
c termini and two separate repressor domains located at the amino-(N) (RD1) and 
carboxy-(C) (RD2) termini of the protein. B.) REST binds to the RE1 consensus 
sequence in the regulatory regions of its target genes. (Adapted from Chong et al., 
1995; Schoenherr et al., 1995; and Ballas et al., 2005) 
B. RE1 Consensus Sequence 
 
 
 
 
  
 
 
A. REST Structure 
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A number of studies have determined that REST binds to a 21-23 base pair 
consensus DNA binding motif called the RE1 element in the regulatory region of its 
target genes (Fig. 2B) (13, 14, 20, 21). These sites may be proximal or distal to the 
transcription start site, or they may be located within introns (20). Recent genome-wide 
analysis of potential RE1 sites revealed that there are over 1,892 human, 1894 mouse, 
and 554 Fugu RE1 sites identified as potential target genes of REST (20). Many of these 
genes are expressed within the nervous system and known to encode essential neuronal 
traits such as ion channels, synaptic vesicle proteins, vesicular trafficking/fusion, and 
neurotransmitter receptors (20, 25). Due to the number of RE1 sites, REST target genes 
are divided into three classes. Target genes that are directly upregulated in the absence of 
REST are known as class I genes (17, 19). Class II REST target genes require both the 
absence of REST function as well as the presence of other positive activators (17, 19). 
There is a new emerging class of REST target genes, Class III, that require both the 
absence of REST as well as relief from other repressive activities, such as CoREST (21). 
Interestingly, the genome-wide sequence also revealed that some short-
noncoding RNA, known as microRNAs (miRs), have RE1 binding sites. MiRs regulate 
gene expression at the post-transcriptional level by binding to the 3’ untranslated regions 
(3’UTR) of their target messenger RNA (mRNAs) and silence gene expression by either 
degrading the mRNA, or reducing translation efficiency during tissue development (26-
30). Specifically, REST regulates expression of many miRs known to promote neuronal 
differentiation such as miR-124a, miR-9, and miR-132 (22). One of the first miRs shown 
to be regulated by REST was miR-124a, which is known to repress non-neuronal 
transcripts. Thus, in non-neural cells, REST binds to miR-124a to repress its expression 
 9 
and promote non-neuronal transcripts (31, 32). However, in neuronal cells, REST is no 
longer repressing miR-124a, causing rapid degradation of non-neuronal transcripts 
allowing a neuronal phenotype (31). Additionally, in mouse ESCs, REST represses 
expression of miR-21, a negative regulator of some self-renewal genes such as Sox2, c-
Myc, Nanog, and Oct4 (33).   
To further assess the importance of REST-mediated repression on neurogenesis, 
previous studies constructed a recombinant transcription factor, REST-VP16, which 
binds to the same DNA binding site but instead of the two repressor domains, it contains 
an activation domain of herpes simplex virus protein VP16 (34). This group found that 
REST-VP16 can compete with endogenous REST for binding and transcriptionally 
activate REST target genes (35, 36). Additionally, in NSCs, the direct activation of 
REST target genes by REST-VP16 was sufficient to induce differentiation of NSCs into 
functionally active neurons and convert the cells into a mature neuronal phenotype (35).  
Moreover, REST can function as an activator of a subset of its own neuronal 
target genes in adult neurogenesis. When REST was bound to a non-coding double 
stranded RNA (dsRNA) with similar homology to the RE1 site, REST functioned as an 
activator of its target neuronal differentiation genes in NSCs leading to neuronal 
differentiation (37).  
REST itself is regulated at the post-translational level. In non-neural cells, β-
Transducin repeat-containing protein (β-TRCP), an E3 ligase, promotes degron-
mediated proteosomal degradation of REST during the G2 phase of the cell cycle (24). 
Similarly, when ESCs progress on their way to lineage restricted neural progenitors, 
REST protein is degraded by β-TRCP-mediated ubiquitylation and the proteosomal 
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degradation complex (23). At this point, although protein levels are being lowered by 
degradation, the REST-corepressor complex still occupies and represses its target genes. 
This repression in NSCs is weak in comparison to the repression in non-neural cells and 
ESCs, where neuronal genes must be permanently silenced (17). REST transcript levels 
do not decrease until the NSCs exit the cell cycle and differentiate into neurons. REST 
transcription was shown to be negatively regulated by the binding of the unliganded 
retinoic acid receptor element (RARE) found on the REST promoter (15). The 
downregulation of REST expression concomitant with neuronal lineage specification is 
associated with derepression of REST target genes (15, 21, 22). 
REST is an Oncogene in Neural Tumors 
Medulloblastoma, a malignant pediatric brain tumor, is characterized by poor 
neuronal differentiation and hyper-proliferation (3, 35, 38). Previous studies have shown 
elevated REST expression in human MB samples compared to normal age-matched 
cerebella (35, 38). These results suggest a defect in pathways controlling the 
downregulation of REST expression (21, 38). Countering REST expression in the human 
MB cell line, DAOY, abrogated the tumorigenic potential of these cells in mouse 
orthotopic models (38). Conversely, v-myc immortalized mouse cerebellar progenitor 
cells (NSC-Ms) engineered to constitutively express REST under a doxycycline 
promoter (NSC-MRs) failed to differentiate and maintained a proliferative state as 
shown by an immunocytochemical assay for BrdU incorporation (Fig. 3) (3). 
Additionally, ectopic REST expression in murine progenitors promoted formation of 
cerebellar tumors in murine cerebellum, implicating REST in MB formation (3) and 
Immunofluorescence Analysis (IFA) showed NSC-MR cells lacked differentiation 
 11 
markers, indicating that they cannot become terminal neurons and offered a proliferative 
advantage. (3). More recently, we have shown that REST expression maintains 
proliferation in MB tumor cells at least in part through regulation of expression of 
p27Kip1 (73).  
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Figure 3: An immunocytochemical assay for BrdU incorporation in NSC-M and 
NSC-MR cells. Cells were plated under either proliferation or differentiation 
condition, BrdU was added to the media and the cells were washed, fixed, and stained 
with anti-BrdU for immunocytochemical analysis. NSC-M cells incorporate BrdU at 
a much lower rate under differentiation conditions compared to proliferation 
conditions. In contrast, NSC-MR cells expressing the human REST transgene (NSC-
MRs -Dox) incorporate BrdU at high rates even when cultured under differentiation 
conditions (3). 
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REST is a Tumor Suppressor in Non-Neural Tumors 
A variety of human tumors arising from epithelial cells of tissues including 
breast, ovarian, colorectal, and lung cancer, show abnormal activation of neuron-specific 
genes. This suggested a defect in the regulators of neuronal genes. REST is normally 
widely expressed throughout non-neural tissues to silence neuronal genes. Therefore, 
when it is deleted or mutated, some of its neuronal genes are aberrantly expressed. REST 
was identified as a frequently deleted gene in colorectal cancer (39). In addition, using 
an RNA interference mechanism, blocking REST function in the mammary epithelial 
cells was shown to cause a transformation phenotype leading to a transformed breast cell 
(39). Thus, the inhibition of REST function seems to be a common event that occurs in 
diverse tissues during normal physiological responses, as well as disease. 
REST Expressing Cells offer a Proliferation Advantage.  
Previous studies showed that NSC-MR cells offer a proliferation advantage over 
NSC-M cells as shown by an immunocytochemical assay for BrdU incorporation (3) 
(Fig. 3). We have shown that REST knockdown in NSC-Ms and human MB cell lines 
(DAOY and D283), inhibits proliferation as shown by a reduced cell number (Fig. 4) 
(73). To verify if this was indeed through a proliferation mechanism, we stained for the 
proliferation marker Ki-67 and found a decrease in Ki-67 positive cells (Fig. 4) (73).  
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Figure 4: REST knockdown by transient transfection in NSC-M cells and two 
MB cell lines (DAOY and D283). Cells were transiently transfected with pooled 
REST specific siRNA or control scrambled (scr) siRNA using DharmaFect transfection 
reagent. REST knockdown promoted a decline in total cell number (left panel) and a 
decline in the number of Ki-67 positive cells (right panel). (73). 
 
Together, these results implicate REST in controlling cell proliferation. REST is 
expressed in the G1 phase of the cell cycle and is targeted for degradation by β-TRCP 
during the G2 phase of the cell cycle (24). Transit through the cell cycle is governed by 
the activity of a family of proteins called the cyclin dependent kinases (CDKs) (Fig. 5).  
These CDKs interact with regulatory subunits known as cyclins and form heterodimers 
to phosphorylate retinoblastoma (RB) and allow progression through the cell cycle (Fig. 
5) (40). The activity of these CDK/Cyclin interactions is controlled by the CDKIs, which 
include the kip family (p21Cip1 and p27Kip1) and the Inhibitor of Kinase 4 family (Ink4) 
(p15Ink4b, p16Ink4a, p18Ink4c) (Fig. 5) (40). CDKIs are known inhibitors of cell 
proliferation. Overall, these results suggest that REST may control cell proliferation by 
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negatively regulating the expression of one or more CDKIs. Our lab recently 
demonstrated a novel role for REST in the regulation of the cell cycle and proliferation 
through negative regulation of p27Kip1 (73). However, the pathways responsible for the 
other CDKIs are still relatively unknown. Interestingly, p16Ink4a expression is relatively 
low in progenitor cells and premature expression of p16Ink4a contributes to the reduced 
self-renewal of neural stem cells in culture (41-43). Furthermore, p16Ink4a expression 
also coincided with a significant decline in proliferation. 
 
 
 
 
 
  
 
 
 
 
Figure 5: Progression through the cell cycle is governed by the CDK-cyclin 
interactions. Transit through the cell cycle is governed by CDK-cyclin interactions.  
Together, they form heterodimers to phosphorylate RB and allow progression through 
the cell cycle. These CDK/Cyclin interactions are negatively regulated by the CDKIs 
(40). 
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Hypothesis 
The overall goal of my project is to elucidate the molecular mechanism(s) underlying 
REST-mediated control of cell proliferation during neuronal differentiation. 
To summarize, we know that: 
1.) REST overexpressing NSC-MR cells offer a proliferation advantage compared to 
NSC-M cells as shown by an immunocytochemical assay for BrdU incorporation 
(3). 
2.) REST knockdown in NSC-M and human MB cell lines promotes a decrease in 
cell number and corresponding decrease in the proliferation marker Ki-67 (73). 
3.) REST is expressed in the G1 phase of the cell cycle and is targeted for 
proteosomal degradation by β-TRCP in G2 phase of the cell cycle (24). 
4.) Progression through the cell cycle is governed by CDK/cyclin activity. The 
CDKS are regulated by CDKIs (40). 
 
The research presented in this dissertation was performed to test the hypothesis 
that REST promotion of proliferation may in part be through negatively regulation of 
expression of CDKIs. Therefore, I will study the relationship between REST and the 
Ink4a/ARF family member, p16Ink4a and demonstrate as follows: 
1.) REST and p16Ink4a correlation 
i. In vivo cerebellum 
ii. In vitro in NSC-M and NSC-MR cell lines 
2.) Mechanism by which REST regulates p16Ink4a 
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Chapter 2 
REST and p16Ink4a expression are reciprocally correlated during neural 
development 
 18 
Rationale 
 
Previous work showed that NSC-MR cells constitutively expressing a human 
REST transgene (NSC-MR) failed to differentiate and continued to proliferate as 
determined by BrdU labeling assays (3). We showed that REST knockdown in NSC-M 
cells promoted a decrease in cell numbers and a corresponding decrease in the 
proliferation marker Ki-67 (73). REST is expressed in the G1 phase of the cell cycle and 
is targeted for degradation by β-TRCP during the G2 phase of the cell cycle (24). 
Progression through the cell cycle is governed by cyclin/CDK activity, which is 
regulated by the CDKIs (40). CDKIs are known to be negative regulators of cell 
proliferation (40). Based on these findings we postulate that REST-mediated control of 
cell proliferation may in part involve negative regulation of CDKI expression or activity. 
Premature expression of p16Ink4a was shown to cause significant decline in proliferation 
and reduced self-renewal of neural stem cells in culture (41-43).   
In this section, we investigated the relationship between REST and the CDKI, 
p16Ink4a, during neurogenesis in differentiating progenitors in vitro and in differentiating 
CPCs of the postnatal cerebellum. We show that REST and p16Ink4a levels are 
reciprocally correlated in the developing mouse cerebellum at postnatal day 7 (P7) and 
P12 by immunofluorescence analysis (IFA). REST and p16Ink4a expression was also 
studied by reverse transcriptase polymerase chain reaction (qRT-PCR), Western Blotting 
(WB) and IFA during neuronal differentiation of progenitors in vitro. We observed that 
REST mRNA and protein levels in NSC-M cells were expressed in progenitors whereas 
p16Ink4a was not. Conversely, REST was downregulated in neurons whereas p16Ink4a was 
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detected. Furthermore, constitutive REST expression in NSC-MR cells blocked 
upregulation of p16Ink4a mRNA and protein levels, even when cultured under 
differentiation conditions. Together, our data suggests a reciprocal relationship between 
REST and p16Ink 4a.  
 20 
Results 
 
REST and p16Ink4a are reciprocally expressed in the developing post-natal 
cerebellum of mice.  
In order to determine if REST reciprocally correlated with p16Ink4a in vivo, REST 
and p16Ink4a protein was analyzed in the developing cerebellum of P7 and P12 mice. 
C57BL6 mice were mated and the brains of the resulting pups were harvested using 
IACUC approved protocols various days after birth and analyzed by IFA assays using 
commercially available anti-REST (red) or anti-p16Ink4a (green) antibodies. In P7 mice, 
REST is mostly in the proliferating cells of the EGL where cells are undergoing 
maximal proliferation while p16Ink4a is in the post-mitotic and terminally differentiated 
neurons of the ML and IGL (Fig. 6). In P12 mice, REST levels are declining as the EGL 
is diminished to a few layers of progenitor cells (Fig. 6). Most of the cells are now 
expressing p16Ink4a and are post-mitotic and terminally differentiated neurons (Fig. 6).  
 21 
 
 
 
 
 
 
 
 
Figure 6: REST and p16Ink4a are reciprocally expressed in the developing post-
natal cerebellum of mice.  C57BL6 wild-type mice were mated and the brains of 
the resulting pups were harvested using IACUC approved protocols. REST and 
p16Ink4a protein in normal P7 and P12 mouse cerebellum was measured by 
immunofluorescence assay using commercially available anti-REST (red) and anti-
p16Ink4a (green) antibodies. Nuclei were stained with Hoechst dye and representative 
images were captured using a 10X lens (top panel) or 40X oil immersion lens 
(middle and bottom panel) on a Nikon fluorescence microscope. Images were 
analyzed with Metamorph software. Experiments were performed in duplicate.  
EGL-External Granule Layer;  IGL- Internal Granule Layer. 
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 REST expressing cells blocked p16Ink4a upregulation. 
To examine the relationship between REST and p16Ink4a during neuronal 
differentiation of neural progenitors in vitro, NSC-M cells were cultured under 
proliferation or differentiation conditions. Total RNA was collected and mRNA levels 
were quantified by qRT-PCR analyses. Relative REST and p16Ink4a mRNA levels were 
determined following normalization to 18S mRNA levels. Downregulation of REST gene 
expression during neuronal differentiation significantly correlated with upregulation of 
p16Ink4a gene expression (Fig. 7). The terminal differentiation marker Synapsin1 (Syn1) 
was used as a positive control since it is an established REST target gene. 
 Conversely, NSC-MR cells cultured under these conditions maintained REST 
expression and failed to upregulate p16Ink4a mRNA levels, even when cultured under 
neuronal differentiation conditions (Fig. 7). Together these findings suggest that 
maintenance of REST expression and a failure to upregulate p16Ink4a expression may 
contribute to uncontrolled proliferation of NSC-MR cells.  
 
 
 
 
 
 
 
 
 
 23 
A. 
 
 
 
 
 
 
B. 
 
 
 
 
 
 
C. 
 24 
D. 
 
 
 
 
 
 
E. 
 
 
 
 
 
 
 
Figure 7: Maintenance of REST expression blocks p16Ink4a upregulation. NSC-M 
(A, B, and C) and NSC-MR (D, and E) cells were grown under proliferation or 
differentiation conditions. Total RNA was prepared, converted to cDNA and analyzed 
by SYBR Green qRT-PCR to measure changes in gene expression of REST, p16Ink4a, 
and Synapsin1 (Syn1). Experiments were done in triplicate, and error bars are 
indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05, **p<0.01). 
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Lowered p16Ink4a protein levels in Neural Progenitors with Constitutive REST 
expression 
To further validate the reciprocal relationship between REST and p16Ink4a during 
neuronal differentiation of neural progenitors, we analyzed protein levels by WB. NSC-
M and NSC-MR cells were cultured under proliferation or differentiation conditions and 
whole cell extracts were analyzed by WB and probed with commercially available anti-
REST or anti-p16Ink4a antibodies (Fig. 8A). Actin was used as a loading control. In NSC-
M cells, REST levels decline upon neuronal differentiation while p16Ink4a levels are 
upregulated (Fig. 8A). In contrast, REST levels do not change in NSC-MR cells cultured 
under differentiation conditions and these cells failed to upregulate p16Ink4a levels (Fig. 
8A). 
REST and p16Ink4a protein levels and sub-cellular localization were also studied 
by IFA.  NSC-M and NSC-MR cells were cultured in CC2 chamber slides under either 
proliferation or differentiation conditions, fixed and stained with anti-REST (red) or 
anti-p16Ink4a antibodies (green).  4’6-diamidino-2-phenylindole (DAPI) (blue) was used 
to stain the nuclei. In NSC-M cells, REST was detected in both the nucleus and 
cytoplasm of progenitor cells but was only detected in the cytoplasm of differentiated 
neurons (Fig. 8B). In contrast, p16Ink4a was not expressed in progenitor cells and was 
only expressed in the nucleus of differentiated neurons (Fig. 8B). Thus, downregulation 
of REST protein levels during neuronal differentiation in NSC-M cells correlated with 
upregulation of p16Ink4a protein levels (Fig. 8B). Conversely, NSC-MR cells maintained 
REST levels and blocked upregulation of p16Ink4a protein levels, even when cultured 
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under neuronal differentiation conditions (Fig. 8B), thereby confirming our findings in 
Fig. 7 and Fig. 8A.  
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 28 
Figure 8: Maintenance of REST levels blocks p16Ink4a upregulation. NSC-M and 
NSC-MR cells were cultured under proliferation or differentiation conditions. A.) 
Whole cell extracts were analyzed by Western blotting to measure changes in REST 
and p16Ink4a protein levels. Actin was used as a loading control. Experiments were 
done in triplicate. Actin was used as a loading control. Experiments were done in 
triplicate. B.) Cells were processed by IFA to detect changes in protein levels and 
sub-cellular localization of REST and p16Ink4a in NSC-M and NSC-MR cells. Cells 
were stained using commercially available anti-REST and anti-p16Ink4a antibodies. 
Nuclei were stained with DAPI. These representative images were captured using a 
Nikon fluorescence microscope and analyzed with Metamorph software. 
Experiments were done in duplicate.  
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Summary 
  
In this section, we investigated the relationship between REST and p16Ink4a 
transcript and protein in mouse brain sections and in differentiating neural progenitors in 
vitro. Tissue sections were obtained and analyzed in the developing cerebellum of P7 
and P12 mice for REST and p16Ink4a. We found REST and p16Ink4a expression in the 
proliferating cells of the EGL and post-mitotic/terminally differentiated neurons of the 
IGL respectively. We also cultured NSC-M cells under proliferation or differentiation 
conditions and demonstrated a decline in REST expression and increase in p16Ink4a 
expression during neurogenesis of NSC-M cells by qRT-PCR, WB, and IFA. Conversely, 
constitutive REST expression in NSC-MR cells blocked upregulation of p16Ink4a, even 
when cultured under differentiation conditions. These findings suggested a reciprocal 
relationship between REST and p16Ink4a. The mechanism by which REST may regulate 
p16Ink4a will be discussed in the next section.   
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Chapter 3 
REST represses miR-203, a negative regulator of Bmi-1, to prevent p16Ink4a 
expression and allow cell proliferation. 
 31 
Rationale 
 
In the previous section, we demonstrated a reciprocal relationship between REST 
and p16Ink4a in neural progenitors in vivo and in vitro. Since REST is a transcriptional 
repressor, we first asked if REST directly controlled p16Ink4a expression. We conducted a 
search of the upstream and downstream regulatory regions of p16Ink4a gene for consensus 
RE1 binding sites. However, the search did not reveal REST binding sites in the p16Ink4a 
regulatory regions, suggesting that the effect of REST on p16Ink4a may be indirect. 
Several lines of evidence have implicated the polycomb gene, B- lymphoma Moloney 
leukemia virus insertion region (Bmi-1), as a negative regulator of p16Ink4a gene 
expression (41-45). Bmi-1 is essential for cerebellar development and is important for 
regulation of CPC proliferation (42, 43, 46, 47). Bmi-1 null mice exhibit a precocious 
increase in p16Ink4a expression that contributed to the reduced self-renewal of neural 
stem cells in culture (43). It is a downstream target of the Shh pathway and aberrantly 
high levels of Bmi-1 are found in many cancers, including medulloblastomas (46). Other 
studies have shown that Bmi-1 is regulated by short non-coding regulatory RNA called 
microRNAs (miRs) such as miR-15a, miR-16 and miR-203 (48, 49). Importantly, REST 
controls the expression of miRs, specifically miR-9, miR-124 and miR-132 (32, 50, 51). 
 In this section, we investigated the hypothesis that REST mediated control of 
p16Ink4a expression is through repression of miRs known to regulate Bmi-1 expression, 
as outlined in Fig. 9. We examined this hypothesis during neurogenesis in differentiating 
progenitors in vitro and in differentiating CPCs of the postnatal cerebellum. Additionally, 
we first examined in NSC-M and NSC-MR cells the expression of a panel of miRs 
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known to regulate Bmi-1 by TaqMan MicroRNA assay followed by qRT-PCR validation 
(in collaboration with Dr. George Calin’s Lab). We then examined REST and Bmi-1 
protein in vivo in the developing mouse cerebellum at P7 and P12 by IFA. We did a 
chromatin immunoprecipitation (ChIP) experiment to show REST binding to the RE1 
element in the downstream regulatory region of miR-203 in NSC-M and NSC-MR cells. 
In our working model, we suggest that REST-mediated repression of miR-203 maintains 
Bmi-1 expression and blocks p16Ink4a expression (Fig. 9).  
 
 
 
 
 
Figure 9. REST-mediated control of cell proliferation- Working Model. REST 
contributes to increased cell proliferation by repressing the expression of miR-203, 
which negatively regulates Bmi-1. Therefore, Bmi-1 can inactivate p16Ink4a, increasing 
cell proliferation and allowing progression through the cell cycle.  
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Results 
 
REST-dependent Changes in miR-203 expression. 
We first asked whether REST dependent negative control of p16Ink4a was 
mediated by a miR and Bmi-1. To assess this, NSC-M and NSC-MR cells were cultured 
under proliferation and differentiation conditions. The expression of a panel of miRs 
known to control Bmi-1 were examined by TaqMan MicroRNA assay followed by qRT-
PCR analyses. Gene expression was determined following normalization to U6 small 
nuclear RNA (RNU6B) mRNA levels. Of these, miR-203 and miR-183 showed a REST-
dependent downregulation of expression (Fig. 10A). The expression of the other 
microRNAs failed to fluctuate in a REST dependent manner. Of these two miRs, only 
miR-203 had a RE1 site and therefore had the potential to be bound by REST. As 
highlighted in Fig. 10B, miR-203 expression was significantly downregulated in REST 
overexpressing NSC-MR cells relative to NSC-M cells. 
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Figure 10: MiR-203 and miR-183 fluctuate in a REST dependent manner. NSC-
M and NSC-MR cells were grown under proliferation conditions. Total RNA was 
prepared and miR expression was quantified by TaqMan MicroRNA assay followed 
by qRT-PCR analyses to measure changes in miR expression. A.) MiR expression of 
a panel of miRs known to regulate Bmi-1. B.) Mir-203 expression is significantly 
downregulated in NSC-MR cells relative to NSC-M cells. Experiments were done in 
triplicate, and error bars are indicated. Statistical analysis was done using Statistica 
6.0 (*p<0.05, **p<0.01). 
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Constitutive REST expression blocked miR-203 upregulation and maintained Bmi-
1 expression in differentiated neural progenitors. 
 To better understand the relationship between REST, miR-203, and Bmi-1 
expression we cultured NSC-M cells under either proliferation or differentiation 
conditions. Total RNA was collected, converted to cDNA and 18s, Bmi-1, Syn1, and 
REST gene expression quantified by SYBR Green qRT-PCR. For miR-203 
measurements, total RNA was collected and mRNA levels were assessed by TaqMan 
MicroRNA assay followed by qRT-PCR analyses. REST gene expression (normalized to 
18S expression) and miR-203 (normalized to RNU6B expression) mRNA levels were 
found to be reciprocally correlated in differentiating NSC-M cells (Fig. 11). This shows 
downregulation of REST gene expression during neuronal differentiation caused a 
significant upregulation of miR-203 gene expression (Fig. 11). The terminal 
differentiation marker Synapsin (Syn1), a known REST target gene was upregulated 
under these conditions and was used as positive control. Importantly, Bmi-1 mRNA 
levels were downregulated concomitant with a decline in REST mRNA levels during 
neuronal differentiation (Fig. 11).  
 In contrast, maintenance of REST expression in NSC-MR cells blocked the 
upregulation of miR-203 mRNA levels, even when cultured under differentiation 
conditions (Fig. 12). This correlated with maintenance of Bmi-1 mRNA levels in these 
cells (Fig. 12).  
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Figure 11: REST gene expression and miR-203 mRNA levels were found to be 
reciprocally correlated in differentiating NSC-M cells. NSC-M cells were grown 
under proliferation or differentiation conditions. A.) Total RNA was prepared, 
converted to cDNA and analyzed by SYBR Green qRT-PCR to measure changes in 
gene expression of REST and Bmi-1. B.) Total RNA was prepared, and mRNA levels 
assessed by Taqman MicroRNA assay followed by qRT-PCR analyses to measure 
changes in gene expression of miR-203. Experiments were done in triplicate, and error 
bars are indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05, 
**p<0.01). C.) Total RNA was prepared, converted to cDNA and analyzed by SYBR 
Green qRT-PCR to measure changes in gene expression of Synapsin1 (Syn1). 
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Figure 12: Maintenance of REST expression blocks miR-203 upregulation and 
maintains Bmi-1 expression. NSC-MR cells were grown under proliferation or 
differentiation conditions. Total RNA was prepared, converted to cDNA and analyzed 
by SYBR Green qRT-PCR to measure changes in gene expression of REST, Bmi-1, 
and Synapsin1 (Syn1). For miR-203, total RNA was prepared, and mRNA levels 
assessed by Taqman MicroRNA assay followed by qRT-PCR analyses to measure 
changes in gene expression. Experiments were done in triplicate, and error bars are 
indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05, **p<0.01). 
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Constitutive REST expression maintains Bmi-1 levels.  
 REST and Bmi-1 sub-cellular localization was also studied by IFA analyses.  
NSC-M and NSC-MR cells were cultured in CC2 chamber slides under either 
proliferation or differentiation conditions, fixed and stained with anti-REST (red) or 
anti-Bmi-1 (green) antibodies. DAPI (blue) was used to stain the nuclei. In NSC-M cells, 
REST was detected in both the nucleus and cytoplasm of progenitor NSC-M cells but 
was only detected in the cytoplasm of differentiated neurons (Fig. 13). Bmi-1 was found 
predominantly in the nucleus of the proliferating NSC-M cells and was not detected in 
NSC-M differentiated cells (Fig. 13). Thus, downregulation of REST protein levels 
during neuronal differentiation in NSC-M cells coincided with downregulation of Bmi-1 
protein levels (Fig. 13). Conversely, NSC-MR cells failed to differentiate and instead 
maintained REST and Bmi-1 protein levels (Fig. 13). REST was detected in the nucleus 
and cytoplasm of NSC-MR cells under both proliferation and differentiation conditions. 
Bmi-1 was predominantly found in the nucleus of NSC-MR cells, even when cultured 
under neuronal differentiation conditions. These findings further confirmed our findings 
in Figs. 11, and 12.   
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Figure 13: Constitutive REST expression maintains Bmi-1 levels.  NSC-M and 
NSC-MR cells were cultured under proliferation or differentiation conditions. Cells 
were processed by IFA to detect changes in protein levels and sub-cellular localization 
of REST and Bmi-1 in NSC-M and NSC-MR cells. Cells were stained using 
commercially available anti-REST and anti-Bmi-1 antibodies. Nuclei were stained 
with DAPI. These images were captured using a Nikon microscope and analyzed with 
Metamorph software. Experiments were done in duplicate.  
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REST and Bmi-1 are expressed in the progenitor cells of the mouse cerebellum. 
To determine if REST and Bmi-1 were concomitantly expressed in the 
proliferating cells of the EGL in vivo, REST and Bmi-1 protein levels were analyzed in 
the developing cerebellum of P7 and P12 mice. C57BL6 mice were mated and the brains 
of the resulting pups were harvested using IACUC approved protocols various days after 
birth and analyzed by IFA assays using commercially available anti-REST (red) or anti-
Bmi-1 (green) antibodies. In P7 mice, REST and Bmi-1 are detected in the proliferating 
cells of the EGL but their levels are substantially reduced upon migration and they are 
barely detected in the IGL (Fig. 14).  In P12 mice, the EGL is diminished to a few layers 
of progenitor cells and most cells in the cerebellum are now migrating post-mitotic and 
terminally differentiated neurons. REST and Bmi-1 are barely detected in any of the 
layers in P12 mice (Fig. 14).  
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Figure 14: REST and Bmi-1 are expressed in the proliferating cells of the EGL. 
REST and Bmi-1 are concomitantly expressed in the EGL of the developing post-natal 
cerebellum of mice. C57BL6 mice were mated and the brains of the resulting pups 
were harvested using IACUC approved protocols various days after birth. REST and 
Bmi-1 protein in normal P7 and P12 mouse cerebellum was measured by 
immunofluorescence assay using commercially available anti-REST (red) and anti-
Bmi-1 (green) antibodies.  Nuclei were stained with Hoechst dye and representative 
images were captured using an Oil Immersion 40X lens on a Nikon fluorescence 
microscope. Images were analyzed with Metamorph software.  Experiments were 
performed in duplicate.  EGL- External Granule Layer, IGL-Internal Granule Layer.  
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REST binds to miR-203 regulatory regions in NSC-M and NSC-MR cells.  
To determine if miR-203 was a direct target of REST, we performed chromatin 
immunoprecipitation (ChIP) assays on proliferating NSC-MRs and NSC-M cells, and 
differentiating NSC-Ms. Cross-linked nuclear extracts were immunoprecipitated using 
rabbit anti-REST antibodies or control rabbit immunoglobulin (IgG). Samples were 
analyzed by qPCR using primers specific to mouse miR-203 and the sample values 
(REST) minus the control values (IgG) were used to determine relative levels of REST 
binding. We observed that REST bound to the regulatory region of miR-203 in NSC-M 
and NSC-MR cells. Additionally, REST showed a significantly higher binding to the 
miR-203 regulatory region relative to IgG controls in proliferating NSC-MR cells 
compared to NSC-M cells plated under the same conditions (Fig. 15). Furthermore, 
REST binding to miR-203 was significantly higher in proliferating NSC-M cells 
compared to differentiated cells (Fig. 15). Together, these data suggests that miR-203 
may be a direct REST target.  
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Figure 15: REST binds to the miR-203 regulatory region in NSC-M and NSC-
MR cells. Chromatin Immunoprecipitation (ChIP) assays were performed as follows: 
Cross-linked nuclear extracts prepared from proliferating NSC-MRs and NSC-M 
cells, and differentiating NSC-Ms were immunoprecipitated using rabbit anti-REST 
antibodies or control rabbit immunoglobulin (IgG). Samples were analyzed by qPCR 
using primers specific to mouse miR-203 and the sample values (REST) minus the 
control values (IgG) were used to determine relative levels of REST binding.  
Experiments were done in triplicate, and error bars are indicated. Statistical analysis 
was done using Statistica 6.0 (*p<0.05, **p<0.01). 
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Summary 
 
 In this section, we investigated the mechanism by which REST regulates p16Ink4a 
expression. We observed miR-203 expression was lower in NSC-MR cells relative to 
NSC-M cells as detected by Taqman MicroRNA assay followed by qRT-PCR analyses. 
Additionally, ChIP analyses revealed REST binding to the RE1 element in the 
downstream regulatory region of miR-203.  Onset of neuronal differentiation in NSC-M 
cells was accompanied by a decrease in REST and Bmi-1 expression and an increase in 
miR-203 expression. Maintenance of REST expression in NSC-MR cells blocked the 
differentiated associated decline in Bmi-1 levels and increased in miR-203, respectively.  
In vivo, IFA analyses showed REST and Bmi-1 protein at high levels in the EGL of the 
developing cerebella with their levels being substantially reduced upon migration to the 
ML and IGL. 
 Our findings suggested that REST may contribute to increased cell proliferation 
by repressing the expression of miR-203, a negative regulator of Bmi-1.  Maintenance of 
Bmi-1 expression prevented p16Ink4a transcription.  
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Chapter 4 
Discussion 
 48 
REST expression promotes cell proliferation in neural progenitor cells 
 REST is a negative regulator of neuronal phenotype and key regulator of brain 
development in vertebrates (13, 14, 19). It is a transcriptional repressor of neuronal 
differentiation genes. REST is expressed in ESCs, NSCs, and non-neural cells, but is 
downregulated in most neurons, consistent with its role as a negative regulator of 
neuronal gene expression (13, 14, 19, 21). In ESCs and NSCs, REST prevents the 
premature expression of terminal neuronal differentiation genes by binding to the RE1 
element in the regulatory regions of its target genes (13, 14). Thus, most recent studies 
have examined REST in the context of its function in the regulation of neuronal 
differentiation genes.  Our recent studies are the first to attribute a novel role for REST 
in the control of cell proliferation and cell cycle exit (73).  We observed that ectopic 
human REST transgene expression in NSC-Ms facilitated sustained proliferation, even 
under differentiation conditions (3). Conversely, REST knockdown in NSC-M cells 
caused a decline in cell numbers concomitant with a decrease in cell proliferation (73). 
Together, our studies suggest that REST may function as a molecular switch that 
coordinates cessation of cell proliferation with onset of neuronal differentiation (73). 
The underlying molecular mechanism(s) of REST regulating proliferation is the major 
goal of the current thesis project.  
REST negatively regulates cell cycle exit  
 Consistent with a potential role for REST in the regulation of cell proliferation, it 
is expressed only in the G1 phase of the cell cycle (24). Cell cycle exit is one of the 
fundamental steps that must occur for cells to cease proliferating and begin expressing 
terminal differentiation markers required for a neuronal phenotype. Transition through 
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the cell cycle is governed by the activity of the cyclin/CDK complexes (40). These 
complexes promote phosphorylation of RB protein, inactivating it, and allowing 
progression through the cell cycle (40). The activity of CDK/cyclin complexes in turn is 
regulated by the CDKIs (40). Given the importance of CDKIs in cerebellar development, 
we examined if the expression of one or more of these CDKIs were subject to negative 
regulation by REST. In the current study, we have identified the CDKI, p16Ink4a, as a 
downstream target of the REST pathway and suggest that REST-dependent control of 
cell proliferation may be achieved by repression of p16Ink4a expression.  
p16Ink4a is a negative regulator of cell cycle progression 
Work from several laboratories has linked p16Ink4a to the regulation of cell 
proliferation in various progenitors and its dysregulated expression to oncogenesis (40, 
55, 56, 68). p16Ink4a expression is relatively low in proliferating neural progenitor cells 
with ubiquitous expression occurring only later in life when cells are terminally 
differentiated (52-54, 58). Its activation leads to growth arrest, senescence and apoptosis 
(52-54).  In neural progenitors, its premature expression causes a significant decline in 
proliferation and reduces self-renewal of NSCs in culture (41-43). Interestingly, p16Ink4a 
is necessary for cell cycle exit, but its expression alone is insufficient to induce neuronal 
differentiation (58). Other INK4a proteins, such as p15Ink4b, are required to induce 
neuronal differentiation (58). The p16Ink4a gene, located on human chromosome 9p21, is 
frequently deleted in many cancers including melanoma, glioblastoma, leukemia, and 
medulloblastoma, suggesting that it functions as a tumor suppressor (40, 55, 56).  
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REST and p16Ink4a are negatively correlated in vivo and in vitro during 
differentiation of neural progenitor cells 
In the current study, we have established a reciprocal pattern of expression 
between REST and p16Ink4a in the developing postnatal cerebellum of mice. REST 
expression was detected almost exclusively in the proliferating progenitors of the EGL 
of P7 cerebella, a developmental stage at which maximal proliferation of progenitors is 
observed. REST levels decline as cells exit the cell cycle and initiate their migration 
down the ML to the IGL, where they become terminally differentiated neurons. Our 
findings are consistent with that by Ravanpay and colleagues, who also showed REST 
expression in the proliferating cells of the EGL (57).  In contrast, p16Ink4a was not found 
in the proliferating cells of the EGL, but showed significant expression in the post-
mitotic and terminally differentiated neurons of the IGL. These observations are similar 
to findings by the Roussel group where they show p16Ink4a to be expressed post-natally 
in neurons (58).  In older P12 mice, the cerebellar EGL is largely depleted of progenitors 
with a vast majority of these cells having terminally differentiated into neurons of the 
IGL. Consistent with diminished proliferation rates of CPCs in the murine P12 cerebella, 
REST expression is detected only at very low levels in these cells. These findings are 
again similar to that described by the Olson group (57). The significant increase in 
p16Ink4a levels in most post-mitotic cells of the P12 murine cerebellum is in line with its 
function as a CDKI.  
These observations were recapitulated in vitro during neuronal differentiation of 
NSC-M neural progenitors. REST has been shown to be expressed in neural progenitors 
and be downregulated in neurons (13, 14, 19) while p16Ink4a has been shown to be 
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expressed only in differentiated neurons (58). Our observations showed that 
downregulation of REST mRNA and protein levels coincided with upregulation of 
p16Ink4a mRNA and protein levels during neuronal differentiation of NSC-M cells, 
consistent with previous studies. Interestingly, as seen by IFA, NSC-MR cells show 
REST to be localized in the cytoplasm as well as in the nucleus. This potentially 
suggests a role for REST in regulating itself through a negative feedback loop when its 
levels exceed a certain threshold.  This feedback loop may cause REST to be degraded 
and therefore be expressed in the cytoplasm and may be a subject worth investigating. 
Collectively, these findings indicate a reciprocal relationship between REST and p16Ink4a.   
Furthermore, constitutive expression of human REST transgene in NSC-MR cells 
blocked upregulation of p16Ink4a mRNA and protein levels, even under neuronal 
differentiation conditions. These findings suggest a potential role of REST expression in 
contributing to uncontrolled proliferation of NSC-MR cells by regulating p16Ink4a 
expression. We further validated our findings by protein and sub cellular localization 
through IFA in NSC-M and NSC-MR cells and together, all of these findings 
recapitulated the reciprocal relationship between REST and p16Ink4a. The mechanism by 
which this relationship occurs is discussed below and is a sub aim of the current thesis 
project. 
REST indirectly regulates p16Ink4a expression 
 REST is a transcriptional repressor that regulates expression of many neuron-
specific genes by binding a motif called the RE1 element present in the regulatory 
regions of its target genes. Since our observations suggest that these changes in p16Ink4a 
expression may be in response to differences in REST levels or activity during neuronal 
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differentiation, we first asked if REST had the potential to regulate p16Ink4a transcription 
(13, 20, 21).  We conducted a computational analysis of the p16Ink4a locus for a 
consensus RE1 binding site, however, this search did not reveal the REST binding motif, 
suggesting that the effect of REST on p16Ink4a may be indirect.   
Bmi-1 transcriptionally regulates p16Ink4a expression 
 Previous studies have linked Bmi-1, a polycomb group gene and epigenetic 
regulator of gene expression (60, 61) to the transcriptional regulation of p16Ink4a in CPCs. 
Bmi-1 mediated control of the Ink4a locus that encodes p16Ink4a is important for the 
maintenance of proliferation and self-renewal potential in these progenitor cells as 
demonstrated by the following studies (59, 60, 62). In Bmi-1 null (Bmi-1-/-) mice, 
p16Ink4a is precociously upregulated in NSCs and progenitor cells causing a reduction in 
self-renewal leading to a morphologically smaller cerebella, including significantly 
thinner granular and molecular cells layers (43). Loss of INK4a in Bmi-1-/- mice 
prevents neurogenesis in vivo and partially rescued the defect in self-renewal, suggesting 
that repression of p16Ink4a is necessary for stem cell self-renewal in the presence of Bmi-
1 (42). These findings led us to hypothesize that REST-dependent transcriptional 
regulation of p16Ink4a expression maybe mediated by Bmi-1.  
REST maintains Bmi-1 expression by repressing miR-203  
 However, the absence of a RE1 site in the upstream or downstream regulatory 
region of Bmi-1 gene makes it unlikely to be a direct target of REST. Interestingly, 
recent reports in the literature identified Bmi-1 as a target of microRNAs (miRs), 
specifically of miR-15a and miR-16, in ovarian cancer (48) and miR-203 in pancreatic 
cells (49). MicroRNAs are important for the control of neurogenesis and neural cell fate 
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specification during brain development (64). Some of the most widely expressed miRs in 
the nervous system, including miR-124 and miR-9 (22, 31-33), are regulated by REST. 
This led us to suspect that REST-dependent maintenance of Bmi-1 expression may be 
through a miR known to negatively regulate Bmi-1. Our subsequent studies led us to 
identify miR-203 as a direct REST target as measured by qRT-PCR analyses and ChIP 
assays. REST showed significant binding to the miR-203 regulatory region relative to 
IgG controls in NSC-M and NSC-MR cells. Our observations are consistent with other 
studies that have demonstrated that miR-203 interacting with REST in the mouse NSC 
line, NS5 (50). Additionally, miR-203 has a stemness-inhibiting and pro-differentiation 
function in skin progenitor cells (65) and was previously shown to directly inhibit Bmi-1 
expression in human pancreatic cancer cells (49). Finally, although we have focused on 
miR-203 in our studies, miR-183 expression also changed in a REST-dependent manner.  
However, the lack of a RE1 motif suggests that its expression may be controlled by other 
intermediate REST target genes.  
 Previous work using mouse ESCs also showed that induction of neuronal 
differentiation was associated with a decrease in Bmi-1 levels and a reciprocal increase 
in miR-203 expression (49). We observed a similar decline in REST and Bmi-1, and an 
increase in miR-203 expression during neuronal differentiation of neural progenitors in 
vitro. This also corroborates other results from previous studies where Bmi-1 expression 
is reduced (66) and miR-203 expression increases as cells differentiate (49).  
 In contrast, constitutive-REST expressing NSC-MR cells blocked the 
upregulation of miR-203 expression during neuronal differentiation and maintained Bmi-
1 expression. This data coincided with previous work that shows NSC-MR cells fail to 
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differentiate and have sustained proliferation (3). We further validated our findings by 
protein and sub cellular localization through IFA in NSC-M and NSC-MR cells. This 
provides the first connection between REST and Bmi-1 through miR-203 and potentially 
with self-renewal of CPCs (50). Reporter assays will provide further in vitro 
confirmation of these relationships.   
 In vivo, we established a concomitant pattern of expression between REST and 
Bmi-1 in the developing postnatal cerebellum of mice. REST and Bmi-1 expression was 
detected almost solely in the proliferating progenitors of the EGL of P7 cerebella.  REST 
and Bmi-1 levels decline as cells exit the cell cycle and initiate their migration down the 
ML to the IGL, where they become terminally differentiated neurons. In older P12 mice, 
REST and Bmi-1 expression are detected only at very low levels, consistent with 
diminished proliferation potential of CPCs in the murine P12 cerebella. 
 Our in vivo and in vitro studies described provide the basis for further 
investigations in the relationship between REST, miR-203, Bmi-1, and p16Ink4a in the 
regulation of cell proliferation and self-renewal of neural progenitors in mice with 
conditional REST knockout in the cerebellum. In vitro, elevated expression of either 
REST or Bmi-1 causes sustained proliferation of immortalized neural progenitors (3, 46). 
Hyper-proliferation is a hallmark of cancers and consistent with this, knockdown of Bmi-
1 or REST in human MB cell lines suppresses their tumorigenic potential in mouse 
orthotopic models (35, 67).  Elevated levels of REST (unpublished data) or lower levels 
of p16Ink4a (68) expression in tumor tissue of patients with MB have been independently 
associated with poor prognosis. Maintenance of REST and Bmi-1 leads to inhibition of 
miR-203 and p16Ink4a and may contribute to uncontrolled proliferation of progenitor cells 
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and potentially tumorigenic cells.  It would be interesting to assess the involvement of 
miR-203 and p16Ink4a in the process of tumorigenesis in mouse models of the disease (3). 
Attenuation of REST signaling may have therapeutic implications and could be 
potentially achieved by upregulating miR-203 in these tumors. Additional studies are 
needed to provide a better understanding of how deregulation of this pathway may 
contribute to tumor formation of MB.   
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Chapter 5 
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Conclusions 
We have demonstrated that: 
1. REST and p16Ink4a are reciprocally expressed in the developing post-natal                          
cerebellum of mice. 
We showed that in P7 mice, where maximal proliferation of CPCs is observed, 
REST is expressed in the proliferating cells of the expanding EGL but not in the 
differentiated neurons of the cerebellum.  Conversely, p16Ink4a was not found in the 
proliferating cells of the EGL and was only expressed in the post-mitotic and 
terminally differentiated neurons of the IGL. In P12 mice where cells are 
predominantly post-mitotic, REST levels are substantially reduced.  In contrast, 
p16Ink4a was detected in these post-mitotic and terminally differentiated cells of P12 
mice.  
2. REST and p16Ink4a are reciprocally correlated in vitro during neuronal 
differentiation of progenitor cells  
We cultured NSC-M cells under proliferation or differentiation conditions and we 
observed downregulation of REST mRNA and protein levels coincident with 
upregulation of p16Ink4a mRNA and protein levels upon onset of neuronal 
differentiation.  
3. Constitutive REST expression in progenitors (NSC-MR cells) blocks 
upregulation of p16Ink4a.  
We observed that maintenance of REST expression in NSC-MR cells enforced 
suppression of  p16Ink4a mRNA and protein expression in NSC-MR cells both under 
proliferation and differentiation conditions.  
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4. REST-dependent regulation of p16Ink4a appears to be indirect since p16Ink4a 
lacks a REST binding site.  
5. The polycomb protein Bmi-1, a known repressor of p16Ink4a transcription is 
positively correlated with REST in proliferating progenitors and differentiated 
neurons in the murine cerebellum.  
In P7 mice, REST and Bmi-1 are both expressed in the proliferating progenitor cells 
of the expanding EGL but not in the differentiated neurons of the IGL.  In P12 mice, 
where most progenitors are post-mitotic, REST and Bmi-1 levels are substantially 
reduced or absent.   
6. In vitro, the expression of Bmi-1 is maintained in proliferating REST-expressing 
CPCs and NSC-M cells but not in differentiated neurons where REST was 
absent as well.  
We cultured NSC-M cells under proliferation or differentiation conditions and 
observed downregulation of REST mRNA and protein levels during neuronal 
differentiation, which coincided with a decline in Bmi-1 mRNA and protein level.  
Conversely, NSC-MR cells that express REST in a constitutive manner maintained 
Bmi-1 expression under proliferation and differentiation conditions.  
7. MiR-203, a negative regulator of Bmi-1 expression shows a pattern of 
expression that is reciprocal to the expression of REST and Bmi-1 in 
proliferating and differentiating progenitors.  
We cultured NSC-M cells under proliferation or differentiation conditions and 
observed downregulation of REST mRNA and protein levels during neuronal 
differentiation, which coincided with an increase in miR-203 expression.  
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8. Constitutive REST expression blocked upregulation of miR-203 in NSC-MR 
cells. We observed that constitutive REST expression in NSC-MR cells prevented 
upregulation of miR-203 expression.  
9. REST binds to the downstream regulatory region of miR-203 in NSC-M and 
NSC-MR cells.  
We showed that REST significantly binds to the miR-203 regulatory region relative 
to control immunoglobulin in NSC-M and NSC-MR cells.  
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Future Directions 
 
1. To investigate the correlation between REST, miR-203, Bmi-1 and p16Ink4a in 
primary progenitors 
In further validate our findings in NSC-M progenitors, our next step would be to see 
how REST and p16Ink4a are correlated in primary progenitors grown under either 
proliferation or differentiation conditions. miR-203 and Bmi-1 expression will also 
be assessed in these cells. We believe that REST and Bmi-1 mRNA and protein levels 
would decline under neuronal differentiation while miR-203 and p16Ink4a would be 
upregulated, confirming the reciprocal correlation seen in NSC-M cells.  
2. To investigate miR-203, Bmi-1 and p16Ink4a expression n mice with conditional 
knockdown of REST expression in CPCs. 
To further investigate the effect of REST knockdown on p16Ink4a expression and cell 
proliferation, mice lacking REST expression in the cerebellar EGL are being 
generated.  The expression of Bmi-1 and p16Ink4a will be examined by 
immunofluorescence assay using cerebella harvested from animals at various times 
after birth.  The expression of these molecules as well as miR-203 will be studied by 
qRT-PCR/Western blotting in vitro in dissociated primary progenitors. We anticipate 
that by inhibiting REST, Bmi-1 would also be downregulated while p16Ink4a would 
be upregulated.  
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3.  To examine the effect of miR-203 overexpression on Bmi-1 and p16Ink4a 
expression. 
In our current study, we showed that REST overexpression causes a downregulation 
of miR-203 levels. Therefore we propose that countering REST expression by 
overexpressing miR-203 might abrogate proliferation of these cells through 
downregulation of Bmi-1 expression and upregulation of p16Ink4a. NSC-M cells, 
NSC-MR cells, and primary progenitors will be transfected with miR-203 or control 
non-specific oligonucleotides.  First changes in cell numbers will be plotted. Next, 
cell extracts will be subjected to Western blotting and immunofluorescence assay. 
We expect that constitutive miR-203 expression will cause a decline in proliferation 
and cell numbers through repression of Bmi-1 expression and consequent 
upregulation of p16Ink4a levels.  
4.  To interrogate if miR-203 is a direct target of REST using reporter assays. 
We showed in the current study that REST binds the RE1 element in the miR-203 
regulatory region, suggesting that it may be a direct REST target. We will use clone 
the RE1 element from the miR-203 locus into reporter constructs and luciferase 
assays will be performed to confirm REST-dependent changes in reporter gene 
expression in NSC-M and NSC-MR cells. The RE1 site will also be mutated to 
abolish REST binding and changes in reporter gene expression will be evaluated in 
NSC-M and NSC-MR cells.  We expect miR-203 luciferase activity to be 
significantly lower in NSC-MR cells compared to NSC-M cells.  Further, we expect 
miR-203 luciferase activity to be upregulated when the RE1 site is mutated.   
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5. To study the relationship between REST and p16Ink4a in human 
medulloblastomas known to express REST at elevated levels. 
A major goal of our laboratory is to investigate the oncogenic function of REST in 
medulloblastoma, which are undifferentiated, hyperproliferative cancer arising from 
the cerebellar granular progenitors. Our previous and ongoing studies have 
demonstrated elevated REST expression in human medulloblastoma samples and 
shown this to be associated with poor prognostic significance for patients with the 
disease (38, 35, Taylor et al., in preparation). We also showed REST to contribute to 
blockade of neuronal differentiation and to be important for tumor progression and 
maintenance using mouse orthotopic models (38). Our recent studies have implicated 
elevated REST expression in neural progenitors to the deregulation of cell 
proliferation (73). Based on the findings of this thesis project, we propose that 
elevated REST expression in medulloblastoma may repress miR-203 expression and 
lead to failure in p16Ink4a.  We will use genetic and biochemical approaches in vitro 
and in vivo to test this hypothesis. 
6. To evaluate the therapeutic potential of constitutive miR-203 expression in 
REST-expressing medulloblastoma in mouse orthotopic models.   
If miR-203 expression is important for upregulation of p16Ink4a transcription and 
inhibiting cell cycle progression, then its expression is also likely to abrogate the 
tumorigenic potential of REST-expressing human medulloblastoma cells, a postulate 
that will be tested in mouse orthotopic models.  
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Chapter 6  
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6.1  Cell Culture 
 The mouse multipotent C17.2 (NSC-M) cell line (3, 69) was derived from 
neonatal mouse cerebellum and was cultured at 5% carbon dioxide, at 37°C in medium 
containing Dulbecco’s modified Eagle’s medium, (DMEM), 10% fetal bovine serum 
(FBS), 5% heat inactivated horse serum (HS), 2 mM l-glutamine, and 1% 
antibiotic/antimycotic solution (PSF) (all from Invitrogen, Carlsbad, CA). For 
proliferation conditions, cells were plated at a low confluency (30%), grown in 
proliferation medium (DMEM, 10%FBS, 5% HS, 2mM l-glutamine, and 1% 
antiobiotic/antimycotic solution) and collected after a day. NSC-M cells are known to 
differentiate at high confluency, so for differentiation conditions, cells were plated at 
50% confluency, allowed to grow in proliferation medium to 100% confluency and 
collected after 5 days. NSC-M cells engineered to constitutively express REST (NSC-
MR) under a doxycycline regulable promoter (previously described in Su and 
Gopalakrishnan, 2006 (3)) were cultured in both proliferation and differentiation 
conditions as described above.   
6.2  Total RNA Isolation 
 Total RNA was extracted from NSC-M and NSC-MR cells using Trizol reagent 
(Invitrogen, Carlsbad, CA) and Chloroform (Sigma-Aldrich, St. Louis, MO) according 
to the Trizol manufacturer’s guidelines (Invitrogen, Carlsbad, CA).  Briefly, media was 
removed and 1ml of Trizol reagent was used to disrupt the cell pellet. 0.2ml of 
chloroform was added to lyse the cells followed by centrifugation (Hettich Rotina 35R, 
Hettich Zentrifugen, Hettich, Germany) at 12,000g for 15 minutes (min) at 4°C. The 
aqueous upper phase was collected in a minicentrifuge tube, precipitated with 0.5ml of 
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Isopropanal, and centrifuged at 12,000g for 10 min at 4°C. The pellet was then washed 
with 1ml of 75% ethanol, centrifuged at 7,500g for 5 min at 4°C, dried and resuspended 
in RNAse-free water.  RNA concentration was determined by spectrophotometric 
analysis (Nanodrop 1000 spectrophotometer, Thermo Scientific, Rockford, IL) and 
stored at -80°C. All experiments were performed in triplicate.  
6.3  Quantitative Reverse Transcriptase Polymerase Chain Reaction (qRT-PCR) 
 Total RNA was isolated from NSC-M cells and NSC-MR cells grown under 
proliferation or differentiation conditions as described in section 6.1. Complementary 
DNA (cDNA) was synthesized from 1µg of total RNA from NSC-M and NSC-MR using 
the iScript cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). Briefly, 4µl of 4x 
iScript Reaction Mix, 1µl of iScript Reverse Transcriptase and 1µg of Total RNA were 
diluted in water according to the manufacturer’s guidelines. Quantitative PCR (qPCR) 
reactions were done using iQ Syber Green Supermix (Bio-Rad Laboratories, Hercules, 
CA) and primers specific to mouse REST, p16Ink4a, Bmi-1, and Synapsin (Integrated 
DNA Technologies, Coralville, IA).  Gene expression was normalized to mouse 18S 
RNA levels.  Relative mRNA measurements were done using the Comparative ∆∆ct 
method as previously described (70). All experiments were performed in triplicate. 
Primer sequences are as follows:  
Table 1: Forward and Reverse Primers for qRT-PCR 
 
GAAATCACCCTTTAGATGTACCTCATTCCTCAGTATTCCCTTMouse Synapsin
GTTGGCCAGAACCTGGCTGTAGAACTCACGGAGGATGAGGTGMouse 18S
TTCCGATCCAATCTGCTCTGCTGCCAATGGCTCCATGAAMouse Bmi-1
GTTGCCCATCATCATCACCTGGAGCAGCATGGAGTCCGCTGCMouse p16Ink4a
GCTTCTCACCTGAATGAGTCCGCATAGTGCGAACTCACACAGGAGAACGMouse REST
Reverse Primer 5’-3’Forward Primer 5’-3’
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6.4  Western Blotting  
 Pellets were collected from NSC-M cells and NSC-MR cells cultivated under 
proliferating/differentiating conditions as described in section 6.1. Pellets were 
resuspended in 100µl western blot (WB) lysis buffer (50mM potassium chloride (KCL), 
10mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) (pH 7.5), 5mM 
Tris-Chloride (Tris-Cl) (pH 7.5), 10% glycerol, 2mM ethylenediaminetetraacetic acid 
(EDTA), 1mM DTT, 1% Triton X-100, 0.4% octylphenoxypolyethoxyethanol (Igepal), 
1% protease inhibitors (Halt, Thermo Scientific, Rockford, IL) diluted in water) 
followed by sonication (Misonix Sonicator 3000, Misonix Incorporated, Farmingdale, 
NY).  Samples were then spun at 15,000g for 10 min at 4°C to pellet debris and the 
supernatant was collected. Protein concentration was determined using a 1:5 dilution in 
water of Commassie blue reagent (Bio-Rad Protein Assay Dye-Reagent concentrate, 
Bio-Rad Laboratories, Hercules, CA). 995µl of 1:5 diluted Commassie blue reagent was 
mixed with 5µl of Protein and analyzed by spectrophotometric analysis at 600 nm 
(Genesys 10-S, Thermo Electron Corporation, Waltham, MA).  Samples were 
electrophoresed by denaturing polyacrylamide gel electrophoresis (PAGE) using sodium 
dodecyl sulfate (SDS). Electrophoresed proteins were transferred to a Hybond-P 
membrane (GE Healthcare, Little Chalfont, UK) in Transfer Buffer (3.03g Tris, 14.4g 
Glycine, 100ml Methanol, and 900ml of water).  Membranes were blocked with 5% 
milk in Phosphatase Buffered Saline (PBS) with 0.1% Tween and incubated with 
primary antibodies as followed: REST (1:1000, Millipore, Waltham, MA), Bmi-1 
(1:1000, Millipore, Waltham, MA), Tuj1 (1:1000, Covance, Denver, PA), Actin 
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(1:20,000, Cell Signaling, Danvers, MA), p16ink4a (1:1000, Santa Cruz Biotechnology, 
Santa Cruz, CA). Blots were incubated with peroxidase conjugated secondary antibodies 
against rabbit or mouse immunoglobulins (IgGs) and the immunocomplexes were 
visualized using Super Signal West Dura Enhanced Chemiluminescence (ECL) reagent 
(Thermo Scientific Pierce, Rockford, IL) and a Kodak film developer (Eastman Kodak).  
All experiments were performed in triplicate. 
6.5  Chromatin Immunoprecipitation (ChIP) Assay 
 First, we prepared two times cross linking and homogenization mix (XHM) was 
prepared using 100mM Hepes (pH 8.0), 280 mM Sodium Chloride (NaCl), 2mM EDTA 
(pH 8.0), 0.8% Igepal CA-630, and 0.4% Triton X-100 diluted in water to final volume. 
Next we prepared cross-linking buffer (XLB) using XHM diluted 1:2 and protease 
inhibitors diluted in water to final volume. Cells were divided into aliquots of 1 million 
cells and pelleted by centrifugation at 5,000 rpm for 1 min at 4°C and cross-linked using 
XLB mixed with 1% formaldehyde. Samples were mixed by inverting 10 times and 
incubated with rocking for 10 min at room temperature (RT). The cross-linking was 
neutralized by adding 1/10 total volume of 1.4 M Glycine and rocking for 5 min at RT. 
The nuclei were pelleted by centrifugation at 14,000 rpm for 1 minute and then 
resuspended in 1 ml of homogenization buffer (XHM diluted 1:2 and protease inhibitors 
diluted in water to final volume). The nuclei were pelleted by centrifugation at 14,000 
rpm for 1 minute and then washed with 1 ml of Nuclear Wash Buffer (1:10 dilution of 
10X Nuclear Wash Buffer (200 mM Tris-hydochloride (Tris-HCL) (pH 8.0), 10mM 
EDTA (pH 8.0), and 1.5M NaCl) and protease inhibitors diluted in water to final 
volume) twice and centrifuged at 14,000 rpm for 1 minute.  
 68 
Cross-linked NSC-M or NSC-MR cells were resuspended in sonication buffer 
(50 mM Tris-HCL (pH 8.0), 10mM EDTA (pH 8.0), 1% SDS, and protease inhibitors) 
and sonicated. The samples were centrifuged twice for 1 minute each at 14,000 rpm to 
remove debris.  For each set, 10% was saved as input DNA and the remaining 90% was 
diluted 10-fold with ChIP dilution buffer (16.7 mM Tris-HCL (pH 8.0), 167 mM NaCl, 
1.2 mM EDTA (pH 8.0), 1.1% Triton X-100, and protease inhibitors diluted in water to 
the final volume) and pre-cleared by incubation with Protein G magnetic beads for 2 hrs 
at 4°C with shaking. The samples were then centrifuged at 3,000 rpm for 1 minute.  The 
pre-cleared supernatant was incubated with 5µg anti-REST antibody or 5µg control IgG 
for 12 hrs at 4°C with shaking followed by addition of Protein G magnetic beads for 2 
hrs at 4°C with shaking.  Beads were collected by centrifugation at 1,000 rpm for 1 
minute and then washed once with the following buffers: Wash buffer I (10mM Tris-Cl 
(pH 8.0), 150mM NaCl, 2mM EDTA (pH 8.0), 0.1% SDS, 1% Triton X-100 diluted in 
water to the final volume); Wash buffer II (20mM Tris-Cl (pH 8.0), 500mM NaCl, 2mM 
EDTA (pH 8.0), 0.1% SDS, 1% Triton X-100 diluted in water diluted in water to the 
final volume); Wash buffer III (10mM Tris-Cl (pH 8.0), 0.25 M Lithium Chloride (LiCl), 
1mM EDTA (pH 8.0), 1% Igepal CA630, 1% deoxycholate diluted in water to the final 
volume); Wash buffer IV (Tris EDTA (TE) (pH 8.0). After washing, the beads were then 
eluted with elution buffer (2%SDS, 0.2M Sodium Bicarbonate (NaHCO3) diluted in 
water to the final volume) and vortexed at RT for 10 min. The beads were pelleted with 
a magnetic rack and supernatants moved to a new tube and mixed with 1 volume of 2X 
dilution buffer (20mM Tris-HCL (pH 8.0), 2mM EDTA (pH 8.0) diluted in water. 
Elution buffer (Diluted 1:2) was added to inputs. Cross-linking was reversed by adding 
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5M NaCl to a final concentration of 0.3M to the elutants and inputs and incubated at 
65°C for 6 hours. The DNA was purified with a QiaQuick PCR Purification kit (Qiagen, 
Valencia, CA).  Bound DNA was quantified using SYBR-Green qPCR analyses as 
previously described (Das et al., 2010) and analyzed with IQ5 Real-Time PCR Detection 
System (Bio-Rad Laboratories, Hercules, CA). Calculations following normalization to 
input values were done as described previously (71). Briefly, the highest value was set to 
1 and control IgG values were subtracted from the target (REST) value. All experiments 
were performed in triplicate.   Primers used as follows: 
Table 2: ChIP Forward and Reverse Primers. 
 
 
6.6  Immunofluorescence assay (IFA) 
 NSC-M and NSC-MR cells were seeded in Lab-Tek II Chamber Slides (Thermo 
Fisher Scientific, Rochester, NY) under proliferation or differentiation conditions as 
described in section 6.1.  Cells were fixed with 2% buffered paraformaldehyde, blocked 
(5% dry milk, 0.2% Triton-X 100, 1% Goat serum in PBS) and incubated with rabbit 
anti-REST (1:100, Millipore, Waltham, MA), mouse anti-Bmi-1 (1:100,  Millipore, 
Waltham, MA), or mouse anti-p16 (1:150, Santa Cruz Biotechnology, Santa Cruz, CA) 
in PBS for 90 min. After washing with PBS three times for three min, the cells were 
incubated with Cy3-labeled goat anti-rabbit IgG (Amersham, Pittsburgh, PA) or Alexa 
Fluor 488 goat anti-mouse IgG (Invitrogen, Carlsbad, CA) for one hour. They were then 
covered with Slowfade Gold_antifade (Invitrogen, Carlsbad, CA) containing 1 µg/ml 
DAPI and sealed. Images were visualized using a Nikon Fluorescence microscope 
GTCTGTGGTCGTGTAGCCTTAGAAGGCAGCAGACACATGGCTMouse miR-203 (10kb)
Reverse Primers 5’-3’Forward Primer 5’-3’
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(Nikon Inc., Melville, NY) and analyzed using Metamorph software (Molecular Devices, 
Downington, PA). 
6.7  Immunohistochemistry (IHC) 
 Mouse cerebellar sections sample slides were placed on a hot plate for 20 min 
and then deparaffinized and hydrated. Briefly, slides were immersed in xylene for 4 min 
followed by a second treatment for 3 min. Then, the slides were immersed in 100% 
ethanol twice for 2 min, 95% ethanol twice for 1 min, 80% ethanol for 1 min followed 
by PBS twice for 2 min. The slides were then placed in citrate buffer (0.1M Sodium 
Citrate) and steamed for 25 min for antigen retrieval. Tissues were allowed to cool for 
30 min, and then blocked (5% dry milk, 1% goat serum in PBS) for 20 min and 
incubated with rabbit anti-REST (1:50), mouse anti-p16 (1:150), or mouse anti-Bmi-1 
(1:100) in blocking solution at 4°ْC over night in a humid chamber. Slides were washed 
in PBS and incubated with Cy3-or A488 conjugated secondary antibodies (1:800 in PBS, 
Invitrogen, Carlsbad, CA) and then covered with Hoescht 33342 (1:10,000 in PBS). 
Images were visualized using a Nikon Fluorescence microscope and analyzed using 
Metamorph software. 
6.8  Taqman® assay to measure MicroRNA (miR) expression 
Total RNA was isolated from cells using TRIZOL reagent as described in section 
6.2.  Endogenous mature microRNA (miR) levels were quantified using TaqMan® 
MicroRNA assay (Applied Biosystems, Carlsbad, CA).  First, total RNA was reverse 
transcribed using the TaqMan® MicroRNA Reverse Transcription Kit (Applied 
Biosystems, Carlsbad, CA). Briefly, miR specific cDNA was prepared using 100mM 
deoxynucleotide triphosphate (dNTPs), 50 U/µL MultiScribe Reverse Transcriptase, 
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10X Reverse Transcription buffer, 20 U/µL RNase inhibitor, miR primers (U6, miR-203, 
miR-183, miR-221, miR-16, miR-15a, and miR-194, Applied Biosystems, Carlsbad, CA)  
5µg of total RNA and nuclease-free water and amplified using a thermal cycler as 
follows: 30 min at 16°C, 30 min at 42°C, 5 min at 85°C, and 4°C indefinitely. This was 
followed by qPCR using TaqMan® Universal PCR Master Mix, No AmpErase® Uracil 
N-glycosylase (UNG) (Applied Biosystems, Carlsbad, CA). Briefly, cDNA (diluted 1:10 
in water) was mixed with 20X TaqMan MicroRNA Assay, TaqMan 2X Universal PCR 
Master Mix, No AmpErase UNG, and nuclease-free water. This was then run on a 384 
qRT machine (Applied Biosystems, Carlsbad, CA) for 10 min at 95°C, followed by 40 
cycles of 15 seconds at 95°C and 1 minute at 60°C.  Relative abundance of miR fold 
difference relative to U6 small nuclear RNA (RNU6B) expression was done using the 
comparative ∆∆ct method as described earlier (72).  All experiments were performed in 
triplicate. 
6.9     Animals 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee at The University of Texas M.D. Anderson Cancer Center. Mice were 
purchased from Jackson Laboratories (Strain C57BL6) and mated. The brains of the 
resulting pups were harvested various days after birth and fixed in paraformaldehyde and 
paraffin embedded. Tissue sections were analyzed by IFA assays as described in section 
6.7.  
6.10    Statistical Analysis:  
We used STATISTICA 6.0, Anova one-way software to analyze qRT-PCR and 
ChIP data. For qRT-PCR, the treated values (differentiation values) minus the untreated 
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values (proliferation values) were used in a one-way analysis of variance, with post hoc 
analysis using the Fisher least significant difference (LSD) to determine significant 
differences. P < 0.05 was considered statistically significant. For ChIP, the sample 
values (REST) minus the control values (IgG) were used in one-way analysis of variance, 
with post hoc analysis using the Fisher LSD to determine significant differences. P < 
0.05 was considered statistically significant. 
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Supplemental Figures 
 
REST expressing cells blocked p16Ink4a upregulation. 
To examine the relationship between REST and p16Ink4a during neuronal 
differentiation of neural progenitors in vitro, NSC-M cells were cultured under 
proliferation or differentiation conditions. Total RNA was collected and mRNA levels 
were quantified by qRT-PCR analyses. Relative REST and p16Ink4a mRNA levels were 
determined following normalization to 18S mRNA levels, and then normalization to 
proliferation values. Downregulation of REST gene expression during neuronal 
differentiation significantly correlated with upregulation of p16Ink4a gene expression (Fig. 
16). The terminal differentiation marker Synapsin1 (Syn1) was used as a positive control 
since it is an established REST target gene. 
 Conversely, NSC-MR cells cultured under these conditions maintained REST 
expression and failed to upregulate p16Ink4a mRNA levels, even when cultured under 
neuronal differentiation conditions (Fig. 16). Together these findings suggest that 
maintenance of REST expression and a failure to upregulate p16Ink4a expression may 
contribute to uncontrolled proliferation of NSC-MR cells.  
 75 
** 
* 
* 
 Figure 16: Maintenance of REST expression blocks p16Ink4a upregulation. NSC-M 
(top panel) and NSC-MR (bottom panel) cells were grown under proliferation or 
differentiation conditions. Total RNA was prepared, converted to cDNA, and 
analyzed by SYBR Green qRT-PCR to measure changes in gene expression of REST, 
p16Ink4a (p16), and Synapsin1 (Syn1). Experiments were done in triplicate, and error 
bars are indicated. Statistical analysis was done using Statistica 6.0 (*-p<0.05, **-
p<0.01). 
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REST-dependent Changes in miR-203 expression. 
NSC-M and NSC-MR cells were cultured under proliferation and differentiation 
conditions and examined by TaqMan MicroRNA assay followed by qRT-PCR analyses. 
Gene expression was determined following normalization to U6 small nuclear RNA 
(RNU6B) mRNA levels. As highlighted in Fig. 17, miR-203 expression was significantly 
downregulated in REST overexpressing NSC-MR cells relative to NSC-M cells. 
 
  
Figure 17: MiR-203 and miR-183 fluctuate in a REST dependent manner. NSC-M 
and NSC-MR cells were grown under proliferation conditions. Total RNA was 
prepared and miR expression was quantified by TaqMan MicroRNA assay followed 
by qRT-PCR analyses to measure changes in miR expression. Mir-203 expression is 
significantly downregulated in NSC-MR cells relative to NSC-M cells. Experiments 
were done in triplicate, and error bars are indicated. Statistical analysis was done 
using Statistica 6.0 (*p<0.05, **p<0.01). 
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Constitutive REST expression blocked miR-203 upregulation and maintained Bmi-
1 expression in differentiated neural progenitors. 
 To better understand the relationship between REST, miR-203, and Bmi-1 
expression we cultured NSC-M cells under either proliferation or differentiation 
conditions. Total RNA was collected, converted to cDNA and 18s, Bmi-1, Syn1, and 
REST gene expression quantified by SYBR Green qRT-PCR. For miR-203 
measurements, total RNA was collected and mRNA levels were assessed by TaqMan 
MicroRNA assay followed by qRT-PCR analyses. REST gene expression (normalized to 
18S expression, and then proliferation values) and miR-203 (normalized to RNU6B 
expression, and then proliferation values) mRNA levels were found to be reciprocally 
correlated in differentiating NSC-M cells (Fig. 18). This shows downregulation of REST 
gene expression during neuronal differentiation caused a significant upregulation of 
miR-203 gene expression (Fig. 18). The terminal differentiation marker Synapsin (Syn1), 
a known REST target gene was upregulated under these conditions and was used as 
positive control. Importantly, Bmi-1 mRNA levels were downregulated concomitant with 
a decline in REST mRNA levels during neuronal differentiation (Fig. 18).  
 In contrast, maintenance of REST expression in NSC-MR cells blocked the 
upregulation of miR-203 mRNA levels, even when cultured under differentiation 
conditions (Fig. 19). This correlated with maintenance of Bmi-1 mRNA levels in these 
cells (Fig. 19).  
 
 78 
A. 
B. 
 
Figure 18: REST gene expression and miR-203 mRNA levels were found to be 
reciprocally correlated in differentiating NSC-M cells. NSC-M cells were grown 
under proliferation or differentiation conditions. A.) Total RNA was prepared, 
converted to cDNA and analyzed by SYBR Green qRT-PCR to measure changes in 
gene expression of REST, Bmi-1, and Synapsin1 (Syn1). B.) Total RNA was prepared, 
and mRNA levels assessed by Taqman MicroRNA assay followed by qRT-PCR 
analyses to measure changes in gene expression of miR-203. Experiments were done 
in triplicate, and error bars are indicated. Statistical analysis was done using Statistica 
6.0 (*p<0.05, **p<0.01). 
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Figure 19: Maintenance of REST expression blocks miR-203 upregulation and 
maintains Bmi-1 expression. NSC-MR cells were grown under proliferation or 
differentiation conditions. Total RNA was prepared, converted to cDNA and analyzed 
by SYBR Green qRT-PCR to measure changes in gene expression of REST, Bmi-1, 
and Synapsin1 (Syn1). For miR-203, total RNA was prepared, and mRNA levels 
assessed by Taqman MicroRNA assay followed by qRT-PCR analyses to measure 
changes in gene expression. Experiments were done in triplicate, and error bars are 
indicated. Statistical analysis was done using Statistica 6.0 (*p<0.05, **p<0.01). 
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